Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA)

Author: ENDRA Life Sciences, Inc. (Nasdaq: NDRA)

Posted Date: